We use molecular modeling and cheminformatics methods to understand at a molecular level the activity of compounds of biological interest. Computational chemogenomics is employed to do drug repositioning and accelerate the identification of bioactive compounds, of synthetic and natural origin, available for therapeutic molecular targets. We are particularly interested in epigenetic targets.